Popular on Amzeal
- CCHR Wants Increased Consumer Awareness About "Prescriptions for Violence" - 133
- Debbie Reynolds Announces IoT Advisory Board's Final Report on Privacy Standards for IoT - 118
- ALLTRA SonicSwap Expands DeFi Opportunities with Weekly Listings and Global Partnerships - 112
- Bloktopia Launches New Virtual Real Estate Service: Prime Investment Opportunities in the Metaverse - 108
- Boost Crypto Rankings Fast: Exclusive Access to Google News Sites in 36 Hours - 107
- Nurturing Healthy Smiles Through Little Mouth Program - 106
- DTC Computer Supplies Announces Name Change to DES Technologies - 104
- Ledger Wallet: The Secure Crypto Storage Solution Every Investor Needs Today
- Individual Winners and Company Finalists for GCOI 2024 Announced by the Arizona Technology Council and Arizona Commerce Authority
- iGolf Announces Renewed Partnerships with Leaderboard and Beezer Golf
Similar on Amzeal
- Transform Your GameFi Project with Must-Have Tools to Scale & Enhance ROI
- SessionGuardian Recognized as a Representative Vendor in Gartner® Top Strategic Technology 2025
- SessionGuardian Recognized as a Representative Vendor in the Gartner® Top Strategic Technology T
- EasySmile Implant Studio's Launches New Website!
- Tech Developers Poised to Shape Political Landscape in 2024 Election
- New Nonprofit Assumes Operations of MarketLink and Novo Dia Group Technology
- CCHR: Helsinki Medical Code Allows Coerced Research on Mental Health Patients
- TCB Capital Advisors Congratulates Altoida & Gregor Diagnostics on 2024 Merit Awards Recognition
- GyftPro Revolutionizes Holiday Gift Shopping: A 100% AI-Built App by First-Time Developer Launches Just in Time for the Holidays
- Secure Your Crypto with the Top-Rated Wallets: Compare Your Savings Options
Breakthrough Wearable Technology for Stroke Rehabilitation Unveiled at UK Conference
Amzeal News/10561035
LONDON - Amzeal -- The University of Hertfordshire UK and Myovolt Limited have joined forces to tackle a significant challenge in the global rehabilitation market. Together, they are developing innovative wearable technology to improve the functional mobility of millions of people living with disabilities caused by neurological conditions such as stroke and cerebral palsy or brain and spinal cord injury.
The collaboration is spearheaded by leading expert Associate Professor Amit Pujari, a distinguished Fellow of the Royal Academy of Engineering and recognised as one of the emerging healthcare research leaders by the Academy of Medical Sciences, UK.
The partnership with Myovolt will accelerate the development of next-generation wearable therapeutic devices that provide remote rehabilitation treatment in the home. The technology delivers clinically directed Focal Vibration Therapy via comfortable, ultrathin garments that can be worn on upper and lower limbs. This is a drug-free neuromuscular treatment to reduce muscle spasticity and improve functional movement, helping people perform activities of daily living and retain their independence.
Neurological conditions that cause spasticity are on the rise globally with stroke now impacting over 1.3 million people in the UK alone.
More on Amzeal News
"This technology offers the potential to change the way rehabilitation treatment is delivered over the long term for these disabling conditions' says Prof Pujari.
Dr Pujari's team is currently conducting clinical trials with stroke patients at the pioneering rehabilitation clinic Hobbs Rehabilitation in the UK. Initial results will be presented at the MiNT 24 conference on 15th April at the Royal Society of Medicine in London. This event is a forum for leading researchers in the fields of neurotechnology and rehabilitation therapy.
Clinical trials will be expanded in the UK mid 2024 in partnership with Leeds Teaching Hospitals with a focus on validating the technology and ease of use for patient recovery in the home. In parallel, commercialisation work is being fast-tracked with a target of products in market and available for patient use as early as 2025.
"The aim is to make our wearable therapeutic device the most user-friendly and effective solution for spasticity reduction available" says Dr Dianne Jones of Myovolt. " We believe technology can revolutionize the delivery rehabilitation treatment. By making therapy more accessible to people, the severity of symptoms can be managed more effectively to support their recovery over extended periods."
More on Amzeal News
This innovative technology combines treatment and functional performance measurement enabling clinicians to monitor the progress of recovery and ultimately provide personalised rehabilitation tailored to an individual's needs and daily routines.
About Myovolt
New Zealand-based Myovolt is the pioneer of the world's first wearable technology for recovery, movement and rehabilitation, utilising garment-based focal vibration. Clinically proven to dramatically reduce muscle soreness and stiffness, Myovolt has become an essential recovery tool for high-performance athletes and MSK rehabilitation around the world. Myovolt is the result of many years of research and development by experts with a track record of designing performance-enhancing technology for elite and Olympic athletes. For more information, visit www.myovolt.com.
About Dr Amit Pujari
Dr. Amit Pujari is a world-leading biomedical engineer and neuroscientist who researches medical device development and neurophysiology. A Senior Lecturer at the University of Hertfordshire, Prof. Pujari was a recipient of the prestigious Royal Academy of Engineering/Leverhulme Trust Research Fellowship and is also a recipient of the Royal Academy Engineering Industrial Fellowship.
The collaboration is spearheaded by leading expert Associate Professor Amit Pujari, a distinguished Fellow of the Royal Academy of Engineering and recognised as one of the emerging healthcare research leaders by the Academy of Medical Sciences, UK.
The partnership with Myovolt will accelerate the development of next-generation wearable therapeutic devices that provide remote rehabilitation treatment in the home. The technology delivers clinically directed Focal Vibration Therapy via comfortable, ultrathin garments that can be worn on upper and lower limbs. This is a drug-free neuromuscular treatment to reduce muscle spasticity and improve functional movement, helping people perform activities of daily living and retain their independence.
Neurological conditions that cause spasticity are on the rise globally with stroke now impacting over 1.3 million people in the UK alone.
More on Amzeal News
- EasySmile Implant Studio's Launches New Website!
- Exciting New STEM Series Launches in Oakland, NJ — "Electronics Exploration with John the Science Guy!"
- New Case Study Reveals Geofencing Strategies for Churches to Grow Community Reach
- Georgia STAND-UP Hosts "Party at the Polls" to Encourage Voter Turnout on Election Day
- Tech Developers Poised to Shape Political Landscape in 2024 Election
"This technology offers the potential to change the way rehabilitation treatment is delivered over the long term for these disabling conditions' says Prof Pujari.
Dr Pujari's team is currently conducting clinical trials with stroke patients at the pioneering rehabilitation clinic Hobbs Rehabilitation in the UK. Initial results will be presented at the MiNT 24 conference on 15th April at the Royal Society of Medicine in London. This event is a forum for leading researchers in the fields of neurotechnology and rehabilitation therapy.
Clinical trials will be expanded in the UK mid 2024 in partnership with Leeds Teaching Hospitals with a focus on validating the technology and ease of use for patient recovery in the home. In parallel, commercialisation work is being fast-tracked with a target of products in market and available for patient use as early as 2025.
"The aim is to make our wearable therapeutic device the most user-friendly and effective solution for spasticity reduction available" says Dr Dianne Jones of Myovolt. " We believe technology can revolutionize the delivery rehabilitation treatment. By making therapy more accessible to people, the severity of symptoms can be managed more effectively to support their recovery over extended periods."
More on Amzeal News
- Global Uproar Over Violations of Religious Freedom and Rising Intolerance
- New Nonprofit Assumes Operations of MarketLink and Novo Dia Group Technology
- CCHR: Helsinki Medical Code Allows Coerced Research on Mental Health Patients
- TCB Capital Advisors Congratulates Altoida & Gregor Diagnostics on 2024 Merit Awards Recognition
- Secrets of Esus Revealed at Jupiter Inlet
This innovative technology combines treatment and functional performance measurement enabling clinicians to monitor the progress of recovery and ultimately provide personalised rehabilitation tailored to an individual's needs and daily routines.
About Myovolt
New Zealand-based Myovolt is the pioneer of the world's first wearable technology for recovery, movement and rehabilitation, utilising garment-based focal vibration. Clinically proven to dramatically reduce muscle soreness and stiffness, Myovolt has become an essential recovery tool for high-performance athletes and MSK rehabilitation around the world. Myovolt is the result of many years of research and development by experts with a track record of designing performance-enhancing technology for elite and Olympic athletes. For more information, visit www.myovolt.com.
About Dr Amit Pujari
Dr. Amit Pujari is a world-leading biomedical engineer and neuroscientist who researches medical device development and neurophysiology. A Senior Lecturer at the University of Hertfordshire, Prof. Pujari was a recipient of the prestigious Royal Academy of Engineering/Leverhulme Trust Research Fellowship and is also a recipient of the Royal Academy Engineering Industrial Fellowship.
Source: MYOVOLT
0 Comments
Latest on Amzeal News
- iGolf Announces Renewed Partnerships with Leaderboard and Beezer Golf
- Fight or Flight.... at least one other option.... Anatomy and Psychology of a Crisis
- Vantiva's Targets for Net-Zero Greenhouse Gas Emissions by 2050 Validated by the Science Based Targets initiative
- Qualis welcomes Steven C. Miley as Vice President of Contracts
- Jann Klose Signs with The Royalty Network, Releases New Single
- Coker Announces Acquisition of Healthcare Consulting Firm, TTG Healthcare Advisors
- Paul Ormsby is appointed by STS Capital Partners as Senior Vice President of Operations
- J Street Property Services Secures Land for Future Multifamily Development in Kerrville, TX
- Debbie Reynolds Announces IoT Advisory Board's Final Report on Privacy Standards for IoT
- SF Comedy Novel "Sex On the Wrong Brain" Claims Fascist Regimes Limit Reproductive Rights To Fuel Masturbation, Urges Simple Sex Ed Lesson
- OpenSSL Forms Business Advisory Committees: Shape the Future - Join Now!
- Last Chance for Green Card Dreams: DV Lottery Deadline Extended to November 7
- Advisors Mortgage Group Celebrates 25 Years of Building Dreams and Strengthening Communities
- SOVAS Honors the Legacy of James Earl Jones With the Newly Established "The James Earl Jones Prize"
- Nayarit Becomes An Official Tourism Destination of the Los Angeles Lakers
- Nexgen Outfitters Secures GSA Contract, Bringing Premier Outdoor Sporting Goods and Equipment to Federal, State, and Local Agencies
- Onestreet Residential Closes On Hearthside Riverdale Site
- Transform Your Date Night with Lick Pineapple Flavored Massage Oil – The Perfect Gift for New Relationships
- Alessia Moccia of E-uphoria: Bridging Fashion, Art, and Technology in NYC
- sliQue and Forward Robotics Announce Strategic Partnership to Revolutionize Enterprise